CoViD vaccines and thrombotic events: EMA issued warning to patients and healthcare professionals.
作者信息
Merchant Hamid A
机构信息
Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH, United Kingdom.
出版信息
J Pharm Policy Pract. 2021 Mar 24;14(1):32. doi: 10.1186/s40545-021-00315-w.
Abstract
摘要
相似文献
1
CoViD vaccines and thrombotic events: EMA issued warning to patients and healthcare professionals.新冠疫苗与血栓形成事件：欧洲药品管理局向患者和医护人员发出警告。
J Pharm Policy Pract. 2021 Mar 24;14(1):32. doi: 10.1186/s40545-021-00315-w.
2
A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016.运用2008年至2016年间记录的美国食品药品监督管理局（FDA）和欧洲药品管理局（EMA）警告信，对非无菌药品的微生物污染进行质量风险管理（QRM）讨论
PDA J Pharm Sci Technol. 2018 Jan-Feb;72(1):62-72. doi: 10.5731/pdajpst.2016.007252. Epub 2017 Dec 14.
3
Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.在 FDA 发布禁止使用电动组织粉碎器的声明后，良性子宫切除术的实践模式和并发症。
JAMA Surg. 2018 Jun 20;153(6):e180141. doi: 10.1001/jamasurg.2018.0141.
4
Analysis of warning letters issued by the US Food and Drug Administration to clinical investigators, institutional review boards and sponsors: a retrospective study.美国食品药品监督管理局向临床研究人员、机构审查委员会和申办者发出的警告信分析：一项回顾性研究
J Med Ethics. 2015 May;41(5):398-403. doi: 10.1136/medethics-2013-101829. Epub 2014 Jun 25.
5
Incidence of Thrombotic Events and Outcomes in COVID-19 Patients Admitted to Intensive Care Units.入住重症监护病房的新冠患者血栓形成事件及转归的发生率
Cureus. 2020 Oct 21;12(10):e11079. doi: 10.7759/cureus.11079.
6
A study of warning letters issued to clinical investigators by the United States Food and Drug Administration.一项关于美国食品药品监督管理局发给临床研究人员的警告信的研究。
Clin Invest Med. 2004 Jun;27(3):129-34.
7
Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study.2001年至2010年欧洲药品管理局批准的新型药物上市后安全问题的监管预期：一项横断面研究。
Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):687-94. doi: 10.1002/pds.3910. Epub 2015 Nov 11.
8
Compassion fatigue, burnout, compassion satisfaction and perceived stress in healthcare professionals during the COVID-19 health crisis in Spain.在西班牙 COVID-19 健康危机期间，医疗保健专业人员的同情疲劳、倦怠、同情满足和感知压力。
J Clin Nurs. 2020 Nov;29(21-22):4321-4330. doi: 10.1111/jocn.15469. Epub 2020 Sep 15.
9
Low quality of some generic cardiovascular medicinal products represents a matter for growing concern.一些仿制药心血管药物的质量较差，这令人越发感到担忧。
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):176-187. doi: 10.1093/ehjcvp/pvz037.
10
Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study.中国武汉医护人员预防 2019 年冠状病毒病使用个人防护设备的情况：横断面研究。
BMJ. 2020 Jun 10;369:m2195. doi: 10.1136/bmj.m2195.
引用本文的文献
1
Safety of SARS-CoV-2 Vaccination in Patients with Vascular Malformations: Patient-Reported Adverse Vaccine Reactions.血管畸形患者接种新型冠状病毒2疫苗的安全性：患者报告的疫苗不良反应
Ann Vasc Dis. 2023 Jun 25;16(2):101-107. doi: 10.3400/avd.oa.22-00126.
2
Gross Hematuria following SARS-CoV-2 Vaccination.新型冠状病毒2型疫苗接种后出现肉眼血尿。
Case Rep Med. 2023 Mar 1;2023:1225510. doi: 10.1155/2023/1225510. eCollection 2023.
3
Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis.COVID-19 疫苗在 2 型糖尿病患者中的安全性：真实世界数据分析。
Diabetes Metab J. 2023 May;47(3):356-365. doi: 10.4093/dmj.2022.0129. Epub 2023 Mar 6.
4
The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups.免疫在SARS-CoV-2感染发病机制及不同年龄组COVID-19疫苗所产生的保护作用中的角色。
Pathogens. 2023 Feb 15;12(2):329. doi: 10.3390/pathogens12020329.
5
Assessment of COVID-19 Anxiety Levels and Attitudes to COVID-19 Vaccine among Older Adults in Poland: A Pilot Study.波兰老年人对COVID-19的焦虑水平及对COVID-19疫苗态度的评估：一项试点研究
Vaccines (Basel). 2022 Nov 13;10(11):1918. doi: 10.3390/vaccines10111918.
6
COVID-19 Vaccine Hesitancy among Pregnant Women Attending Antenatal Clinics in Pakistan: A Multicentric, Prospective, Survey-Based Study.巴基斯坦产前诊所孕妇对 COVID-19 疫苗的犹豫：一项多中心、前瞻性、基于调查的研究。
Viruses. 2022 Oct 25;14(11):2344. doi: 10.3390/v14112344.
7
A case of aseptic bilateral cavernous sinus thrombosis following a recent inactivated SARS-CoV-2 vaccination.1例近期接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）灭活疫苗后发生的无菌性双侧海绵窦血栓形成病例。
Taiwan J Ophthalmol. 2022 Jun 15;12(3):334-338. doi: 10.4103/tjo.tjo_25_22. eCollection 2022 Jul-Sep.
8
Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants.在微流控平台上进行工程病毒基因组学和纳米脂质体研究，以对 SARS-CoV-2 变体进行个体化分析。
Theranostics. 2022 Jun 6;12(10):4779-4790. doi: 10.7150/thno.72339. eCollection 2022.
9
Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. . 2022, , 1115-1126.关于阿尔登等人的评论。辉瑞生物科技公司新冠病毒mRNA疫苗BNT162b2在人肝细胞系中的体外细胞内逆转录。2022年，第1115 - 1126页。
Curr Issues Mol Biol. 2022 Apr 11;44(4):1661-1663. doi: 10.3390/cimb44040113.
10
Safety Margin for Plasma Hyperviscosity in Cardiovascular Disease Patients after COVID-19 Vaccination for Thrombosis Prevention.新冠病毒疫苗接种后心血管疾病患者预防血栓形成时血浆高粘度的安全边际
Arq Bras Cardiol. 2021 Dec;117(6):1217-1218. doi: 10.36660/abc.20210555.
本文引用的文献
1
Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots.新冠疫情：有报道称出现血栓后，欧洲多国暂停使用牛津-阿斯利康疫苗。
BMJ. 2021 Mar 11;372:n699. doi: 10.1136/bmj.n699.
2
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.辉瑞和莫德纳新冠疫苗接种后出现的血小板减少症。
Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9.
3
Antibody-induced procoagulant platelets in severe COVID-19 infection.严重 COVID-19 感染中的抗体诱导的促凝血小板。
Blood. 2021 Feb 25;137(8):1061-1071. doi: 10.1182/blood.2020008762.
Zotero 插件